Metrika

  • citati u SCIndeksu: 0
  • citati u CrossRef-u:[11]
  • citati u Google Scholaru:[]
  • posete u poslednjih 30 dana:20
  • preuzimanja u poslednjih 30 dana:14

Sadržaj

članak: 1 od 1  
Food and Feed Research
2016, vol. 43, br. 2, str. 103-110
Korisna svojstva probiotskog kvasca Saccharomyces boulardii
Tomičić Zorica M.a ORCID, Čolović Radmilo R.a ORCID, Čabarkapa Ivana S.a ORCID, Vukmirović Đuro M.a, Đuragić Olivera M.a ORCID, Tomičić Ružica M.b ORCID
aInstitut za prehrambene tehnologije, Novi Sad, Srbija
bUniverzitet u Novom Sadu, Tehnološki fakultet, Srbija

e-adresa: zorica.tomicic@fins.uns.ac.rs
Projekat:
Application of novel and conventional processes for removal of m ost com mon contaminants, mycotoxins and salmonella, in order to produce safe animal feed in the territory of AP Vojvodina

Ključne reči: Saccharomyces boulardii; efikasnost; bezbednost; probiotik
Sažetak
Saccharomyces boulardii je jedina vrsta kvasca za koju je dokazano da poseduje svojstva koja karakterišu probiotike. S. boulardii je nepatogeni, termofilni kvasac, koji se koristi u prevenciji i lečenju crevnih oboljenja, uglavnom dijareja. Ova vrsta se odlikuje sposobnošću prolaska kroz gastrointestinalni trakt i deluje inhibitorno na brojne patogene mikroorganizme. Veliki broj kliničkih studija potvrđuje njegovu efikasnost u lečenju akutnih i hroničnih gastrointestinalnih oboljenja. Njegova potencijalna primena u raznim mlečnim proizvodima može da ponudi alternativni probiotski proizvod za ljude koji pate od dijareje. Ovaj pregled razmatra efikasnost i bezbednost S. boulardii kao probiotika za prevenciju i lečenje gastrointestinalnih poremećaja kod ljudi.
Reference

Araújo, A.E., dos Santos, P.A.C., Pinto, S.M., Jan, G., de Carvalho, A.F. (2011) Probiotics in dairy fermented products. u: Rigobelo E. [ur.] Probiotics, InTech

Beniwal, R.S., Arena, V.C., Thomas, L., Narla, S., Imperiale, T.F., Chaudhry, R.A., Ahmad, U.A. (2003) A randomized trial of yogurt for prevention of antibiotic-associated diarrhea. Digestive Diseases and Sciences, 48(10): 2077-2082

Billoo, A.G., Memon, M.A., Khaskheli, S.A., Murtaza, G., Iqbal, K., Saeed, S.M., Siddiqi, A.Q. (2006) Role of a probiotic (Saccharomyces boulardii) in management and prevention of diarrhoea. World journal of gastroenterology, 12(28): 4557-60

Buts, J., de Keyser, N. (2006) Effects of Saccharomyces boulardii on Intestinal Mucosa. Digestive Diseases and Sciences, 51(8): 1485-1492

Cassone, M., Serra, P., Mondello, F., Girolamo, A., Scafetti, S., Pistella, E., Venditti, M. (2003) Outbreak of Saccharomyces cerevisiae subtype boulardii fungemia in patients neighboring those treated with a probiotic preparation of the organism. Journal of clinical microbiology, 41(11): 5340-3

Czerucka, D., Piche, T., Rampal, P. (2007) Yeast as probiotics-Saccharomyces boulardii, review. Aliment Pharmacol Ther.,, 15; 26 (6), 767-78

Czerucka, D., Rampal, P. (2002) Experimental effects of Saccharomyces boulardii on diarrheal pathogens. Microbes and Infection, 4(7): 733-739

FAO (2002) Working group report on drafting guidelines for the evaluation of probiotics in food. London, ON, Canada: Food and Agriculture Organization

Graff, S., Chaumeil, J., Boy, P., Lai-Kuen, R., Charrueau, C. (2008) Formulations for Protecting the Probiotic Saccharomyces boulardii from Degradation in Acidic Condition. Biological & Pharmaceutical Bulletin, 31(2): 266-272

1

Guslandi, M., Mezzi, G., Sorghi, M., Testoni, P.A. (2000) Saccharomyces boulardii in maintenance treatment of Crohn's disease. Dig Dis Sci, 45(7): 1462-4

Guslandi, M., Giollo, P., Testoni, P.A. (2003) A pilot trial of Saccharomyces boulardii in ulcerative colitis. European Journal of Gastroenterology & Hepatology, 15(6): 697-698

Hamilton-Miller, J.M.T. (2004) Probiotics and prebiotics in the elderly. Postgraduate medical journal, 80(946): 447-51

1

Hickson, M. (2011) Probiotics in the prevention of antibiotic-associated diarrhoea and Clostridium difficile infection. Therapeutic Advances in Gastroenterology, 4(3): 185-197

Hill, C., Guarner, F., Reid, G., Gibson, G.R., Merenstein, D.J., Pot, B., Morelli, L., Canani, R.B., Flint, H.J., Salminen, S., Calder, P.C., Sanders, M.E. (2014) Expert consensus document: The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nature Reviews Gastroenterology & Hepatology, 11(8): 506-514

1

Holzapfel, W.H., Haberer, P., Geisen, R., Bjorkroth, J., Schillinger, U. (2001) Taxonomy and important features of probiotic microorganisms in food and nutrition. Am J Clin Nutr, 73(2 Suppl): 365S-373S

ICZN (2014) What is a nomen nudum. London, UK: International Commission on Zoological Nomenclature, http//iczn.org/content/what-nomen-nudum

Karaolis, C., Botsaris, G., Pantelides, I., Tsaltas, D. (2013) Potential application of Saccharomyces boulardii as a probiotic in goat's yoghurt: survival and organoleptic effects. International Journal of Food Science & Technology, 48(7): 1445-1452

Kelesidis, T., Pothoulakis, C. (2012) Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disorders. Therapeutic advances in gastroenterology, 5(2): 111-25

Krasowska, A., Murzyn, A., Dyjankiewicz, A., Łukaszewicz, M., Dziadkowiec, D. (2009) The antagonistic effect of Saccharomyces boulardii on Candida albicans filamentation, adhesion and biofilm formation. FEMS yeast research, 9(8): 1312-21

Kühle, A.van der A., Jespersen, L. (2003) The Taxonomic Position of Saccharomyces boulardii as Evaluated by Sequence Analysis of the D1/D2 Domain of 26S rDNA, the ITS1-5.8S rDNA-ITS2 Region and the Mitochondrial Cytochrome-c Oxidase II Gene. Systematic and Applied Microbiology, 26(4): 564-571

Lourens, A., Viljoen, B.C. (2001) Growth and survival of a probiotic yeast in dairy products. Food Research International, 34(9): 791

Marcia, L.B. (2009) Saccharomyces boulardii as a probiotic for children. Pediatric Pharmacolotherapy, 15 (7); 1-5

McFarland, L. V., Bernasconi, P. (1993) Saccharomyces boulardii'. A Review of an Innovative Biotherapeutic Agent. Microbial Ecology in Health and Disease, 6(4): 157-171

McFarland, L.V. (2010) Systematic review and meta-analysis of Saccharomyces boulardii in adult patients. World Journal of Gastroenterology, 16(18): 2202

Mitterdorfer, G., Mayer, H.K., Kneifel, W., Viernstein, H. (2002) Clustering of Saccharomyces boulardii strains within the species S. cerevisiae using molecular typing techniques. Journal of applied microbiology, 93(4): 521-30

Pothoulakis, C. (2009) Review article: anti-inflammatory mechanisms of action ofSaccharomyces boulardii. Alimentary Pharmacology & Therapeutics, 30(8): 826-833

Qamar, A., Aboudola, S., Warny, M., Michetti, P., Pothoulakis, C., LaMont, J. T., Kelly, C. P. (2001) Saccharomyces boulardii Stimulates Intestinal Immunoglobulin A Immune Response to Clostridium difficile Toxin A in Mice. Infection and Immunity, 69(4): 2762-2765

Sindhu, S. C., Khetarpaul, N. (2002) Effect of Probiotic Fermentation on Antinutrients and In Vitro Protein and Starch Digestibilities of Indigenously Developed RWGT Food Mixture. Nutrition and Health, 16(3): 173-181

Tiago, F. C. P., Martins, F. S., Souza, E. L. S., Pimenta, P. F. P., Araujo, H. R. C., Castro, I. M., Brandao, R. L., Nicoli, J. R. (2012) Adhesion to the yeast cell surface as a mechanism for trapping pathogenic bacteria by Saccharomyces probiotics. Journal of Medical Microbiology, 61(Pt_9): 1194-1207

1

Tomičić, R.M., Čabarkapa, I.S., Vukmirović, Đ.M., Lević, J.D., Tomičić, Z.M. (2016) Influence of growth conditions on biofilm formation of Listeria monocytogenes. Food and Feed Research, vol. 43, br. 1, str. 19-24

1

Tomičić, Z., Zupan, J., Matos, T., Raspor, P. (2016) Probiotic yeast Saccharomyces boulardii (nom. nud.) modulates adhesive properties of Candida glabrata. Medical mycology, 54(8): 835-45

van der Aa, K.A., Skovgaard, K., Jespersen, L. (2005) In vitro screening of probiotic properties of Saccharomyces cerevisiae var. boulardii and food-borne Saccharomyces cerevisiae strains. International journal of food microbiology, 101(1): 29-39

Venugopalan, V., Shriner, K.A., Wong-Beringer, A. (2010) Regulatory oversight and safety of probiotic use. Emerging infectious diseases, 16(11): 1661-5

Whelan, K., Myers, C.E. (2010) Safety of probiotics in patients receiving nutritional support: a systematic review of case reports, randomized controlled trials, and nonrandomized trials. American journal of clinical nutrition, 91(3): 687-703

Wohlgemuth, S., Loh, G., Blaut, M. (2010) Recent developments and perspectives in the investigation of probiotic effects. International journal of medical microbiology, 300(1): 3-10
   

O članku

jezik rada: engleski
vrsta rada: pregledni članak
DOI: 10.5937/FFR1602103T
objavljen u SCIndeksu: 21.01.2017.
Creative Commons License 4.0

Povezani članci

Nema povezanih članaka